These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 11805726)
1. Marketed new antiepileptic drugs: are they better than old-generation agents? Perucca E Ther Drug Monit; 2002 Feb; 24(1):74-80. PubMed ID: 11805726 [TBL] [Abstract][Full Text] [Related]
2. New antiepileptic drugs: review on drug interactions. Hachad H; Ragueneau-Majlessi I; Levy RH Ther Drug Monit; 2002 Feb; 24(1):91-103. PubMed ID: 11805729 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Perucca E Fundam Clin Pharmacol; 2001 Dec; 15(6):405-17. PubMed ID: 11860529 [TBL] [Abstract][Full Text] [Related]
4. [Treatment protocol for long-term anti-epilepsy drugs in adults with refractory partial epilepsy]. Thomas P Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S252-64. PubMed ID: 15331973 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Johannessen SI; Tomson T Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972 [TBL] [Abstract][Full Text] [Related]
6. Newer antiepileptic drugs. Towards an improved risk-benefit ratio. Patsalos PN; Sander JW Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080 [TBL] [Abstract][Full Text] [Related]
7. [Newer antiepileptic drugs]. Matsuura M No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756 [TBL] [Abstract][Full Text] [Related]
8. [Antiepileptic drugs in North America]. Akiyama T; Otsubo H Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099 [TBL] [Abstract][Full Text] [Related]
9. The new antiepileptic drugs: pharmacological and clinical aspects. Gatti G; Bonomi I; Jannuzzi G; Perucca E Curr Pharm Des; 2000 May; 6(8):839-60. PubMed ID: 10828310 [TBL] [Abstract][Full Text] [Related]
10. The new generation of antiepileptic drugs: advantages and disadvantages. Perucca E Br J Clin Pharmacol; 1996 Nov; 42(5):531-43. PubMed ID: 8951184 [TBL] [Abstract][Full Text] [Related]
11. Drug selection for the newly diagnosed patient: when is a new generation antiepileptic drug indicated? Tomson T J Neurol; 2004 Sep; 251(9):1043-9. PubMed ID: 15372244 [TBL] [Abstract][Full Text] [Related]
13. Selection criteria for the clinical use of the newer antiepileptic drugs. Deckers CL; Knoester PD; de Haan GJ; Keyser A; Renier WO; Hekster YA CNS Drugs; 2003; 17(6):405-21. PubMed ID: 12697000 [TBL] [Abstract][Full Text] [Related]
14. A new look at the second-generation antiepileptic drugs: a decade of experience. LaRoche SM Neurologist; 2007 May; 13(3):133-9. PubMed ID: 17495757 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Beghi E Lancet Neurol; 2004 Oct; 3(10):618-21. PubMed ID: 15380158 [TBL] [Abstract][Full Text] [Related]
17. [Current pharmacotherapy of epilepsy in adults]. Beyenburg S Bull Soc Sci Med Grand Duche Luxemb; 2005; (3):263-81. PubMed ID: 17176542 [TBL] [Abstract][Full Text] [Related]
18. Use of second-generation antiepileptic drugs in the pediatric population. Chung AM; Eiland LS Paediatr Drugs; 2008; 10(4):217-54. PubMed ID: 18590343 [TBL] [Abstract][Full Text] [Related]